A Different Approach to Selling a Medical Practice
Zenyte Holdings is assembling portfolios of medical practices in four specialties:
Cardiology • Pain Management • Internal Medicine • Family Practice
Rather than selling individual practices directly to private equity, participating practices are combined into a larger portfolio designed to be valued through the public markets for 5x collections or more.
You don't have to decide today whether you want to sell your practice.
You have approximately six months to evaluate the strategy, review the offers you receive, and decide for yourself.
No money out of pocket to get started. No obligation to sell. You remain in control.
Zenyte assembles practices within Cardiology, Pain Management, Internal Medicine and Family Practice into portfolios rather than attempting to sell each practice individually. The completed portfolios are sold through the public markets and are not sold to Private Equity.
This creates the size, diversification and scale sought by larger buyers.
Each participating practice acquires the VSD ancillary offered by VS Diagnostics.
VSD is the common operating element—or nexus—connecting practices from different specialties into an ancillary-based healthcare portfolio.
Instead of twenty unrelated medical practices, the objective is to create one larger, connected healthcare portfolio.
Zenyte uses their publicly traded company to position the completed portfolio for public-market valuation.
The strategy is designed to achieve valuations of 5x collections or more, with that portfolio valuation flowing down to the participating practices.
You will receive offers approximately 90 days after completing enrollment and providing the necessary financial information.
You then decide whether those offers are attractive enough for you to proceed.
You control the decision.
Depending upon the transaction available to you, you may decide to:
There is no requirement that you sell simply because you evaluated the program.
That's one of the most important questions you should ask.
The strategy isn't based upon a buyer purchasing one medical practice and keeping it as a standalone business.
The objective is to acquire practices at 5x collections or more, combine them into a substantially larger healthcare portfolio, and ultimately achieve a higher valuation for the completed portfolio.
The difference between the acquisition valuation and the eventual portfolio valuation creates the economic opportunity.
Practice → Portfolio → Public Markets
This is fundamentally different from selling a single medical practice to another doctor or negotiating an EBITDA-based transaction with private equity.
Most doctors are familiar with only two.
The buyer is frequently another doctor or small medical group.
Valuations can be relatively low, financing may be limited, and the seller may even be asked to carry part of the purchase price.
Private equity generally focuses heavily on EBITDA and profitability.
For many smaller and midsized practices, achieving the EBITDA required to attract serious private-equity interest can be difficult.
The Zenyte strategy takes a different approach.
Practices are assembled into a portfolio with VSD as the ancillary nexus and positioned for valuation through the public markets.
Target valuation: 5x collections or more.
Review why VSD is required, how the six-month evaluation works, the available exit strategies, and the complete seven-step process.
How It Works